These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32588087)

  • 1. Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells.
    Louisse J; Rijkers D; Stoopen G; Janssen A; Staats M; Hoogenboom R; Kersten S; Peijnenburg A
    Arch Toxicol; 2020 Sep; 94(9):3137-3155. PubMed ID: 32588087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.
    Behr AC; Kwiatkowski A; Ståhlman M; Schmidt FF; Luckert C; Braeuning A; Buhrke T
    Arch Toxicol; 2020 May; 94(5):1673-1686. PubMed ID: 32253466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model.
    Steves AN; Turry A; Gill B; Clarkson-Townsend D; Bradner JM; Bachli I; Caudle WM; Miller GW; Chan AWS; Easley CA
    Syst Biol Reprod Med; 2018 Aug; 64(4):225-239. PubMed ID: 29911897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach methodologies: A quantitative in vitro to in vivo extrapolation case study with PFASs.
    Fragki S; Louisse J; Bokkers B; Luijten M; Peijnenburg A; Rijkers D; Piersma AH; Zeilmaker MJ
    Food Chem Toxicol; 2023 Feb; 172():113559. PubMed ID: 36535450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying novel mechanisms of per- and polyfluoroalkyl substance-induced hepatotoxicity using FRG humanized mice.
    Robarts DR; Paine-Cabrera D; Kotulkar M; Venneman KK; Gunewardena S; Foquet L; Bial G; Apte U
    Arch Toxicol; 2024 Sep; 98(9):3063-3075. PubMed ID: 38782768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polyfluoroalkyl chemical exposure with serum lipids in children.
    Zeng XW; Qian Z; Emo B; Vaughn M; Bao J; Qin XD; Zhu Y; Li J; Lee YL; Dong GH
    Sci Total Environ; 2015 Apr; 512-513():364-370. PubMed ID: 25638651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral, morphometric, and gene expression effects in adult zebrafish (Danio rerio) embryonically exposed to PFOA, PFOS, and PFNA.
    Jantzen CE; Annunziato KM; Cooper KR
    Aquat Toxicol; 2016 Nov; 180():123-130. PubMed ID: 27710860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-life perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) exposure cause obesity by disrupting fatty acids metabolism and enhancing triglyceride synthesis in Caenorhabditis elegans.
    Lin TA; Huang CW; Wei CC
    Aquat Toxicol; 2022 Oct; 251():106274. PubMed ID: 36037606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells.
    Louisse J; Fragki S; Rijkers D; Janssen A; van Dijk B; Leenders L; Staats M; Bokkers B; Zeilmaker M; Piersma A; Luijten M; Hoogenboom R; Peijnenburg A
    Arch Toxicol; 2023 Apr; 97(4):1113-1131. PubMed ID: 36864359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Aug; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
    Bjork JA; Butenhoff JL; Wallace KB
    Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
    Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
    Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association among serum per- and polyfluoroalkyl substances, lipid profile and metabolic syndrome in Czech adults, HBM-EHES survey 2019.
    Puklová V; Čapková N; Fialová A; Vavrouš A; Žejglicová K; Černá M
    Cent Eur J Public Health; 2023 Dec; 31(4):227-234. PubMed ID: 38309699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
    Strömqvist M; Olsson JA; Kärrman A; Brunström B
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.